Dr. Bryan Ardis: The Nicotine Hypothesis, COVID-19 Lies & the Snake-Venom Theory
Dr. Bryan Ardis, DC is a chiropractor and former nutrition-clinic director who emerged as a prominent independent researcher during the COVID-19 era. After his father-in-law’s death in a hospital ICU in 2020 — a death he came to attribute to remdesivir-induced kidney failure rather than the viral illness itself — Dr. Ardis began an extended public investigation into hospital protocols, vaccine injuries, and what he argues is a systematic suppression of low-cost therapeutic interventions. His central public claim is the nicotine hypothesis: that nicotine, decoupled from the carcinogenic combustion byproducts of tobacco smoke, is a powerful, broadly protective antiviral and anti-inflammatory molecule whose therapeutic potential, he argues, has been deliberately concealed in order to protect the global pharmaceutical and tobacco-control industries.
This hub is an extensive, sourced documentation of Dr. Ardis’s research, the arguments laid out in his 2024 book Moving Beyond the COVID-19 Lies, and the broader ecosystem of clinicians, papers, and historical primary sources he draws on. We summarize the nicotine–nAChR receptor pharmacology his thesis rests on; the “synthetic-venom-peptide” reading of the SARS-CoV-2 spike protein he advanced in 2022; his clinical protocols for hospital-injured and vaccine-injured patients; and his historical reading of tobacco as an indigenous medicine that was first commercialized, then demonized, then replaced by patent pharmaceuticals targeting the same receptor system. We present his positions as he states them, attributed to him, with citations to the primary literature he draws on, and with a section on the published science he points to as common ground.
Deep-Dive Articles
Bryan Ardis’s body of work is wide-ranging — book, podcasts, conference talks, peer-reviewed citations, clinical protocols, and historical research. The thirty-one articles below each take one strand of that work and unfold it in depth; articles 15The fourteen articles below each take one strand of that work and unfold it in depth.ndash;31 document, one subject at a time, the research behind the claims he sets out in his 2025 nicotine talks. Start with the page on his book, Moving Beyond the COVID-19 Lies, if you want the integrated argument, or jump straight to the Nicotine Hypothesis if you came here for the receptor pharmacology.
1. Moving Beyond the COVID-19 Lies — The Book
Dr. Ardis’s 2024 book, in his own words: where he says COVID came from, why so many are still unwell, remdesivir, lost taste and smell, and the healing steps he recommends — each topic linked to the page on this site that sets it out.
Read the deep dive →2. The Nicotine Hypothesis
The central thesis: nicotine binds nicotinic acetylcholine receptors (nAChRs) at the same site SARS-CoV-2 spike binds, blocks viral and toxin entry, lowers IL-6/TNF-α via the cholinergic anti-inflammatory pathway, and explains the “smoker’s paradox” in COVID hospitalization data — without committing the user to combustion-tobacco harms.
Read the deep dive →3. Nicotinic Acetylcholine Receptors (nAChRs)
The receptor pharmacology underneath the hypothesis: α7-nAChR distribution on neurons, alveolar macrophages, lymphocytes, and vascular endothelium; the cholinergic anti-inflammatory pathway (Tracey, Nature 2002); the Changeux/Pasteur 2020 nicotinic-hypothesis preprint; and why, for Dr. Ardis, the receptor itself is the target rather than general “immune support.”
Read the deep dive →4. The Synthetic-Venom-Peptide Hypothesis
Dr. Ardis’s 2022 claim, as he states it: spike-protein/conotoxin/elapid-neurotoxin sequence homology and the published 3-finger-toxin literature he cites (Forsström, Lentz, Changeux).
Read the deep dive →5. Nicotine Patch Protocol — Dosing & Sourcing
The practical layer: the 7 mg / 14 mg / 21 mg transdermal patch ladder used in Dr. Ardis’s recovery protocols, why he prefers patches over gum/lozenges, contraindications (pregnancy, unstable cardiac disease, adolescents, MAOI users), sourcing, and a clear taper schedule. This is documentation, not medical advice.
Read the deep dive →6. Vaccine-Injury Recovery Protocol
The full Ardis protocol stack for individuals reporting persistent post-vaccination symptoms: nicotine patches, NAC, vitamin C, melatonin, ivermectin (where legal/available), low-dose aspirin for microclot risk, dandelion-root extract, and structured detox phases. Side-by-side with the FLCCC I-RECOVER protocol for context.
Read the deep dive →7. Hospital Protocols & Remdesivir
The case against the early-pandemic standard of care that Dr. Ardis makes: the ACTT-1 design, the WHO Solidarity trial result, the 33% AKI signal from VA pharmacovigilance, the ventilator-mortality numbers from Ichikado et al., and how CMS bonus payments (Cares Act) created perverse incentives around the 20% inpatient COVID add-on.
Read the deep dive →8. The Ardis Detox Layer
The complementary detox stack he layers on top of nicotine therapy: NAC for glutathione, dandelion-root extract for spike-protein binding (Tran 2021 preprint), pine-needle tea for shikimic acid, fenbendazole and ivermectin in the cancer/immunology layer, methylene blue for mitochondrial rescue, and his cautious view on chelation.
Read the deep dive →9. Tobacco, Indigenous Medicine & Suppression History
The historical layer: pre-Columbian Indigenous medicinal tobacco use, the Royal College of Physicians 2016 e-cigarette report, Surgeon-General Luther Terry’s 1964 framing, the FDA NRT pathway, and the parallel patent timeline of varenicline, galantamine, and other nAChR-active drugs — the “why was nicotine left on the shelf?” argument central to Dr. Ardis’s historical case.
Read the deep dive →10. The Leitzke Long-COVID Cases
The 2023 paper Dr. Ardis cites for his six-day patch protocol: four people with post-COVID syndrome, one low-strength patch a day, and their recovery day by day — smell, taste, energy and breath.
Read the deep dive →11. Cobra Venom and Nicotine
Why Dr. Ardis says the spike protein matches king cobra and krait venom, how cobra three-finger toxins sit in the nicotinic receptor, and why he says nicotine wins the receptor back.
Read the deep dive →12. Pyrazines and Nicotine Addiction
The Harvard study of tobacco additives behind Dr. Ardis’s argument that nicotine alone is not what addicts — walked through section by section, with the full paper to download.
Read the deep dive →13. Nightshade Nicotine and Parkinson’s
Nicotine as a food nutrient in tomatoes, peppers, potatoes and eggplant, and the University of Washington study linking those foods to lower Parkinson’s risk.
Read the deep dive →14. D-Dimer and Snake Venom
Dr. Ardis’s blood-clot argument in his own words: a doctor’s D-dimer results after vaccination, the medical reference whose fifth bullet reads “snake venom poisoning”, and how it led him to the inventors of the mRNA vaccines.
Read the deep dive →15. The Nicotine Addiction Label (1994)
Dr. Ardis on the 1994 congressional hearing, the FDA’s addiction finding and the warning label, beside the hearing record, the court ruling and the label’s actual history.
Read the deep dive →16. FDA User Fees and Drug Advertising
His account of drug approval for an upfront fee and of TV drug commercials, beside the user-fee law, the published fee schedule and research on direct-to-consumer advertising.
Read the deep dive →17. Nicotine and Alzheimer’s Disease
Nicotine as a “nootropic” for memory and dementia, in his words, beside the nicotine-patch trials in memory loss and the receptor research in Alzheimer’s.
Read the deep dive →18. Snus and Multiple Sclerosis
The Swedish snuff research he cites on MS risk, with the Swedish case-control and cohort studies and the animal-model work on nicotine.
Read the deep dive →19. Nicotine Patches for Arthritis and Inflammation
His joint-patch method for arthritis and “anything ending in -itis”, with the research on the vagus-nerve anti-inflammatory pathway and nicotine in pain.
Read the deep dive →20. Nicotine and Ulcerative Colitis
Nicotine for the colon, as he states it, with the transdermal-nicotine and enema trials in ulcerative colitis described as they read.
Read the deep dive →21. Nicotine and Hashimoto’s Thyroiditis
His recommendation for hypothyroidism and Hashimoto’s, with the population studies on smoking, thyroid antibodies and thyroid function.
Read the deep dive →22. Nicotine and Type 1 Diabetes
His statement on beta cells and insulin, with the nicotinic-receptor research in the pancreas and the autoimmune-diabetes animal studies.
Read the deep dive →23. Nicotine and Glioblastoma
The 2021 brain-tumor claim, in his words, with the published laboratory research on nicotinic receptors in glioblastoma cells.
Read the deep dive →24. Nicotine and Autism
His statement on autistic children and adults, with the transdermal-nicotine pilot trial, the brain-tissue receptor studies and the CHRNA7 genetics.
Read the deep dive →25. Nicotine, Myocarditis and Heart Rhythm
Myocarditis, A-fib and the tobacco-leaf foot soak, as he describes them, with the myocarditis animal studies and vagus-nerve heart-rhythm trials.
Read the deep dive →26. Nicotine and Schizophrenia
His statement on schizophrenia, with the self-medication research, the sensory-gating studies and the α7 receptor trials.
Read the deep dive →27. Nicotine and Parasites
Tobacco against worms in his account, with nicotine’s history as an insecticide and the nicotinic drugs used against parasitic worms.
Read the deep dive →28. Tobacco Water and Nanotechnology
The tobacco-water microscope video he presents as an antidote, with the research on graphene oxide, vaccine ingredients and drying-droplet patterns.
Read the deep dive →29. Snake Venom and Long COVID
Venom peptides in COVID-19 patients and the long-COVID symptom list, in his account, with the Brogna papers and the snakebite long-term research.
Read the deep dive →30. Tobacco and Nicotine Bans
The 2030 “endgame” policies he links to his message, beside each government’s own announcements and laws.
Read the deep dive →31. Virus Means Venom
His reading of the Latin word virus, with the classical dictionaries, the history of virology and tobacco in Indigenous snakebite medicine.
Read the deep dive →Who Is Dr. Bryan Ardis?
Bryan Ardis graduated from Parker University in Dallas with a Doctor of Chiropractic (DC) degree. Before COVID, his clinical practice — first in Dallas’s suburbs and later online — focused on chronic-pain rehabilitation, nutritional medicine, and what he describes as “orthomolecular protocols” for autoimmune disease and metabolic dysfunction. He was, by his own account, an entirely conventional alternative-medicine practitioner with no public profile until April 2020.
His pivot into pandemic research began with the death of his father-in-law, John C. Eyman, in a Texas hospital in late March 2020. Dr. Ardis has stated publicly that Eyman was admitted with a respiratory illness, was placed on a five-day course of remdesivir against the family’s objections, developed acute kidney injury (AKI) within 72 hours, was placed on mechanical ventilation, and died. The death certificate listed COVID-19; Dr. Ardis publicly argues the proximate cause was iatrogenic AKI from remdesivir. That experience, he says, began the line of inquiry that runs through all of his later work: if a $3,120 five-day course of an experimental antiviral was being administered with FDA Emergency Use Authorization despite a 33% acute-kidney-injury signal in pharmacovigilance data, what else was being done in the name of pandemic care that did not survive ordinary clinical scrutiny?
From that question, Dr. Ardis broadened his investigation into the FDA Emergency Use Authorization process, the early NIH treatment guidelines, the CARES Act’s 20% Medicare add-on for inpatient COVID admissions, the design of pivotal vaccine trials, and the receptor-pharmacology literature on nicotine and the nicotinic acetylcholine receptor. He launched The Dr. Ardis Show, a long-form interview podcast, in 2021. In 2022 he became internationally known for the Watch the Water documentary advancing the “synthetic-venom-peptide” reading of the SARS-CoV-2 spike protein. In 2024 he published Moving Beyond the COVID-19 Lies: Restoring Health & Hope for Humanity (Harvest Creek Publishing) — his book on the pandemic years, described on this hub’s book page.
Dr. Ardis is a chiropractor, not a medical doctor, and does not practice prescriptive medicine. His chiropractic license is in Texas. The hub focuses on his arguments, as he states them, and the published literature he cites, not on supplement endorsements.
Dr. Ardis’s Thesis on One Page
As Dr. Ardis lays it out, his case runs in six steps:
- SARS-CoV-2 spike binds nicotinic acetylcholine receptors (nAChRs). In his account, the spike receptor-binding domain shares structural homology with snake-venom three-finger toxins (3FTx), which are well-known nAChR antagonists. Multiple peer-reviewed papers (Farsalinos 2020, Changeux 2020, Lagoumintzis 2021) make a version of this claim.
- Nicotine occupies the same receptor. Nicotine is a high-affinity orthosteric agonist at α4β2 and α7 nAChRs. By saturating those receptors, Dr. Ardis says, nicotine can competitively block the spike-glycoprotein/receptor interaction and prevent the receptor-mediated phase of pathology — not the only mechanism of viral injury, but, in his reading, the most under-recognized one. He argues that hospitalized patients are too far down the inflammatory cascade for nicotine to rescue, and that the right test is early outpatient or pre-exposure use.
- The cholinergic anti-inflammatory pathway. Vagal stimulation via α7-nAChR on macrophages potently suppresses IL-6 and TNF-α release (Tracey’s Nature work, 2000–2010). In Dr. Ardis’s reading, this pathway explains, mechanistically, the persistent “smokers were under-represented in COVID ICUs” observational signal.
- The vaccine and the wild-type virus share the receptor target. Because the mRNA platforms generate spike protein endogenously, Dr. Ardis argues the same nAChR-mediated pathology can be a component of post-vaccination injury — and the same receptor occupant (nicotine) can be a component of recovery, alongside conventional detox and anti-inflammatory measures.
- Hospital standard-of-care optimized for billing, not survival. In his account, the remdesivir/ventilator combination produced exceptionally high inpatient mortality, while cheap, generic, off-patent agents (ivermectin, fluvoxamine, hydroxychloroquine, melatonin, vitamin D, zinc, and — centrally — nicotine) were systematically excluded from formularies in a way he argues cannot be explained by clinical evidence alone.
- The nicotine taboo is a 60-year-old policy artifact. Dr. Ardis traces it to the 1964 Surgeon General report, which, in his telling, bundled nicotine with the carcinogens of combusted tobacco. He says that bundling has carried forward into the present day as a near-religious public-health prohibition on naming nicotine as a therapeutic, even as patent drugs targeting the same receptor (varenicline, galantamine) generate billions in revenue.
Reading Paths Through This Hub
Six reading paths through the thirteen deep-dive articles, depending on what brought you here:
- You want the integrated argument. Start with Moving Beyond the COVID-19 Lies — The Book, then The Nicotine Hypothesis, then Hospital Protocols & Remdesivir.
- You came for the receptor pharmacology. Go straight to nAChRs, then The Nicotine Hypothesis. The 3-finger-toxin literature picks up in The Synthetic-Venom-Peptide Hypothesis.
- You came for his nicotine research. Start with The Leitzke Long-COVID Cases, the 2023 paper he cites for his six-day patch protocol; then Pyrazines and Nicotine Addiction, his argument that nicotine alone is not what addicts; then Nightshade Nicotine and Parkinson’s, on nicotine as a food nutrient.
- You or someone you love is dealing with a vaccine injury. The practical layer is Vaccine-Injury Recovery, supported by Patch Dosing & Sourcing and The Ardis Detox Layer. Read these alongside the IMA (formerly FLCCC) — I-RECOVER: Post-Vaccine Treatment protocol for context, and discuss with a clinician who works with post-vaccination patients.
- You came for the snake-venom reading. Start with The Synthetic-Venom-Peptide Hypothesis, his 2022 claim as he states it, then Cobra Venom and Nicotine, on why he says nicotine wins the receptor back. After those, D-Dimer and Snake Venom sets out the blood-test argument that, in his telling, led him to the inventors of the mRNA vaccines; their papers are examined on Snake Venom Phosphodiesterase in the Karikó–Weissman Papers.
- You want the historical and political case. Tobacco, Indigenous Medicine & Suppression History stands alone as a long-form essay on how, in Dr. Ardis’s account, a multi-purpose Indigenous medicine became a pharmaceutical taboo over the course of two centuries.
Common Ground Dr. Ardis Points To
The published science below is the common ground Dr. Ardis points to — the receptor biology and clinical data his argument starts from.
- Nicotine is a high-affinity nAChR agonist. This is undergraduate pharmacology.
- The cholinergic anti-inflammatory pathway exists and is therapeutically relevant. Tracey’s vagus-nerve work (Borovikova et al., Nature 2000; Wang et al., Nature 2003) has been replicated in dozens of laboratories and has spawned an entire bioelectronic-medicine industry.
- The α7-nAChR is expressed on alveolar macrophages, T cells, and pulmonary endothelium — the exact tissues SARS-CoV-2 targets.
- The “smoker’s paradox” in the early-pandemic data. Active smokers were under-represented among hospitalized COVID patients in multiple early French and Chinese cohorts (Miyara 2020, Farsalinos 2020 meta-analysis).
- Remdesivir produces a dose-related signal of acute kidney injury in WHO Uppsala VigiBase pharmacovigilance data; the WHO Solidarity trial showed no mortality benefit (Pan et al., NEJM 2021).
- Three-finger-toxin / nAChR pharmacology is a long-established structural biology field with crystallographic data going back to Bourne & Taylor 2005 and Dellisanti 2007.
Anyone considering a nicotine-based therapy on the basis of this material should discuss it with a clinician who is familiar with both nAChR pharmacology and their own medical history. Pregnancy, unstable coronary disease, recent stroke, uncontrolled hypertension, and adolescence (developing brain) are absolute or near-absolute contraindications to exogenous nicotine. The Patch Protocol page lays them out in detail.
Dr. Ardis’s Own Work
Dr. Bryan Ardis’s nicotine protocol and the reasoning behind it, in his own words — his show, the interviews in which he lays it out, and his book.
- The Dr. Ardis Show — official site
- The Dr. Ardis Show, 28 August 2023 — “Venom Industrial Complex: Weaponizing Venoms” — the 7 mg, six-day nicotine instruction and the long-hauler symptom list.
- The Dr. Ardis Show podcast archive, April 2024 — his nicotine presentation “The Other ‘N’ Word.”
- Myers Detox Podcast #607 — “Nicotine Can Reverse Brain Fog, Inflammation, Dementia, and Chronic Illness” with Dr. Bryan Ardis — full transcript.
- Cosmic Reality Podcast, May 2024 — Dr. Ardis on nicotine and snake venom
- Bryan Ardis, Moving Beyond the COVID-19 Lies: Restoring Health & Hope for Humanity (Harvest Creek Publishing, 2024; ISBN 978-1-961641-22-8) — library record.
- His nicotine protocols, documented by a reader site — the prevention, long-hauler and vaccine-injury instructions from his “How to Use Nicotine” handout.
On this site: Nicotine Patch Protocol · The Leitzke cases · Cobra venom and nicotine · Pyrazines · Nightshade nicotine and Parkinson’s
Key Research Papers
- Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405(6785):458-62. — doi:10.1038/35013070
- Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature. 2003;421(6921):384-8. — doi:10.1038/nature01339
- Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis A, Kouretas D, Vantarakis A, Poulas K. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicology Reports. 2020;7:658-663. — doi:10.1016/j.toxrep.2020.04.012
- Changeux JP, Amoura Z, Rey FA, Miyara M. A nicotinic hypothesis for COVID-19 with preventive and therapeutic implications. Comptes Rendus Biologies. 2020;343(1):33-39. — doi:10.5802/crbiol.8
- Farsalinos K, Eliopoulos E, Leonidas DD, Papadopoulos GE, Tzartos S, Poulas K. Nicotinic cholinergic system and COVID-19: In silico identification of an interaction between SARS-CoV-2 and nicotinic receptors with potential therapeutic targeting implications. Int J Mol Sci. 2020;21(16):5807. — doi:10.3390/ijms21165807
- WHO Solidarity Trial Consortium. Pan H, Peto R, Henao-Restrepo AM, et al. Repurposed antiviral drugs for Covid-19 — Interim WHO Solidarity Trial Results. N Engl J Med. 2021;384(6):497-511. — doi:10.1056/NEJMoa2023184
- Couzin-Frankel J. Long Covid clues emerge from worldwide research effort. Science. 2022. — doi:10.1126/science.add4297
Connections
- The Nicotine Patch: Skin to Bloodstream to Receptor — interactive animation
- Nicotine: The Research — the PubMed research on nicotine, by topic and condition, kept separate from Dr. Ardis’s claims
- All Notable Doctors
- All Remedies
- Anthony Fauci — the same pandemic years from the institutional side, including the released diaries and the Ct-threshold remarks Dr. Ardis cites
- Dr. Abram Hoffer — the psychiatrist-biochemist whose niacin and vitamin C program founded orthomolecular medicine
- Linus Pauling — two Nobel Prizes and the vitamin C research program
- Vaccine-Injury Recovery
- Nicotine Hypothesis
- Snake-Venom Hypothesis
- Nicotinic Acetylcholine Receptors
- Detox and Recovery
- Moving Beyond the COVID-19 Lies (Book)
- The Leitzke Long-COVID Cases
- Cobra Venom and Nicotine
- D-Dimer and Snake Venom
- Snake Venom Phosphodiesterase in the Karikó–Weissman Papers
- Pyrazines and Nicotine Addiction
- Nightshade Nicotine and Parkinson’s
- Nicotine Patch Protocol
- Tobacco Suppression History
- Hospital Protocol Critique
- The Nicotine Addiction Label (1994)
- FDA User Fees and Drug Advertising
- Nicotine and Alzheimer’s Disease
- Snus and Multiple Sclerosis
- Nicotine Patches for Arthritis
- Nicotine and Ulcerative Colitis
- Nicotine and Hashimoto’s
- Nicotine and Type 1 Diabetes
- Nicotine and Glioblastoma
- Nicotine and Autism
- Nicotine, Myocarditis and Heart Rhythm
- Nicotine and Schizophrenia
- Nicotine and Parasites
- Tobacco Water and Nanotechnology
- Snake Venom and Long COVID
- Tobacco and Nicotine Bans
- Virus Means Venom (Latin)
- NAC (N-Acetylcysteine)
- Methylene Blue
- Fenbendazole
- Zinc
- Vitamin C
- Morley Robbins (Root Cause Protocol)
- Gerson Therapy
- Immune Boosting
- Detox Protocols
Featured Videos
